CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020
Current Assets
Cash	$ 81,207	$ 186,873	$ 188,631
Prepaid expenses	90,269	123,039
Deposits	750	750
Total Current Assets	172,226	310,662
Property, plant and equipment, net	191,871	197,336
Right to use asset	38,382	41,991
Total Assets	402,479	549,989
Current Liabilities
Accounts payable and accrued expense	342,468	350,785
Deferred revenue	140,000
Convertible notes payable, net of discounts of $0 and $13,425, respectively		31,575
Convertible notes payable, related parties, net of discounts of $0 and $24,431, respectively		86,169
Convertible notes payable, in default	353,300	308,300
Convertible notes payable, in default - related parties	638,500	527,900
Notes payable, in default	130,000	130,000
Notes payable, in default - related parties	18,500	18,500
Shareholder loan	1,500	1,500
Lease liability, current	15,185	14,680
Total Current Liabilities	1,639,453	1,469,409
Lease liability, long-term	23,621	27,594
Total Liabilities	1,663,074	1,497,003
Stockholders' Deficit
Common stock, $0.0001 par value - 9,900,000,000 shares authorized; 5,400,268,545 and 5,315,683,905 shares issued and outstanding at March 31, 2021 and December 31, 2020 , respectively	538,772	530,315
Common stock to be issued, $0.0001 par value, 1,500,000 shares outstanding	150	150
Unearned compensation	(48,257)	(67,058)
Additional paid-in capital	18,763,117	18,514,376
Accumulated deficit	(20,514,377)	(19,924,797)
Total Stockholders' Deficit	(1,260,595)	(947,014)	(947,014)
Total Liabilities and Stockholders' Deficit	402,479	$ 549,989
Series A
Stockholders' Deficit
Preferred stock, $0.0001 par values - 50,000,000 shares authorized; 67 shares issued; Series A - 7 shares issued and outstanding; Series B - 60 shares issued and outstanding
Series B
Stockholders' Deficit
Preferred stock, $0.0001 par values - 50,000,000 shares authorized; 67 shares issued; Series A - 7 shares issued and outstanding; Series B - 60 shares issued and outstanding